Figure 5.Clinical relevance of fibroblast content and clinical relevance of risk score. (A) The fibroblast content was significantly increased in the advanced stage, advanced T stage, and positive lymph node metastasis groups. (B) The risk score was significantly higher in the advanced stage, advanced T stage, positive lymph node metastasis, and distant metastasis groups.
